Vahid Eslami | Cardiology | Best Researcher Award

Published on by Global Academic Awards

Assoc. Prof. Dr. Vahid Eslami | Cardiology | Best Researcher Award

Assoc. Prof. Dr. Vahid Eslami, Shahid Modarres hospital, Iran

Assoc. Prof. Dr. Vahid Eslami is a board-certified Interventional Cardiologist and Structural Heart Specialist based in Tehran, Iran. With over 14 years of experience, he specializes in high-risk coronary interventions, TAVI, CTO angioplasty, and advanced cardiac imaging (IVUS, OCT). πŸ₯ As Head of the Cardiovascular Department at Shahid Beheshti University, he leads clinical education and research, boasting 50+ peer-reviewed publications and an H-index of 11. πŸŽ“ A Fellow of the American College of Cardiology and member of ESC, EAPCI, and ISOIC, Dr. Eslami actively mentors cardiology trainees and presents at global cardiology congresses.

Publication Profile

Google Scholar

Professional Experience

Assoc. Prof. Dr. Vahid Eslami is a distinguished Interventional Cardiologist and Head of the Cardiovascular Department at Shahid Beheshti Medical University, Tehran. With over a decade of clinical and academic excellence, he has led multidisciplinary teams, performed over 500 complex coronary interventions, and implemented advanced imaging technologies like IVUS and OCT. πŸ“ˆ He has overseen impactful research, contributing to 20+ high-impact publications and international conference presentations. πŸ₯ As a medical educator, he has trained over 100 cardiology residents and fellows. πŸ§‘β€βš•οΈ A respected leader and national board member for myocardial infarction treatment, he actively shapes Iran’s cardiovascular protocols. 🌍

πŸŽ“ Education & Medical Training

Dr. Vahid Eslami completed his Doctor of Medicine (MD) at Tehran University of Medical Sciences (1999–2006), ranking 11th among 300,000 applicants in the national entrance exam. πŸ… He pursued a Cardiology Residency (2006–2010) at Shahid Beheshti University of Medical Sciences, where his thesis on QT dispersion post-primary PCI was published in a U.S. journal. πŸ«€ He then completed a Fellowship in Interventional Cardiology (2012–2014) at the same university, focusing on coronary angiography and FFR, with his research again featured in international journals. πŸ“˜ His training solidified his expertise in advanced cardiovascular care and research

πŸ… Licenses & Certifications

Dr. Vahid Eslami is a board-certified Interventional Cardiologist, accredited by the American College of Cardiology (ACC) πŸŽ“. He holds active memberships in several esteemed cardiology organizations, including the American College of Cardiology , the European Association of Percutaneous Cardiovascular Interventions (EAPCI) , and the Iranian Society of Interventional Cardiology (ISOIC) . These affiliations reflect his global engagement and adherence to the highest standards of cardiovascular care.His certifications and memberships support his ongoing contributions to research, education, and innovation in interventional cardiology.

πŸ§ πŸ”¬ Research Focus

Assoc. Prof. Dr. Vahid Eslami’s research is deeply rooted in interventional cardiology, with significant contributions to COVID-19 cardiovascular outcomes , anticoagulation therapies, and ischemic heart disease. His studies focus on complex coronary interventions, QT interval dynamics, inflammatory biomarkers, and gender differences in cardiac risk. He’s actively involved in randomized controlled trials and has examined the visual-functional mismatch in coronary diagnostics. He also explores the role of epicardial fat and cardiac imaging indices in disease progression. His multidisciplinary work bridges clinical practice and cardiovascular research, advancing protocols for acute and critical care cardiology

Publication Top Notes

  • πŸ“„ Effect of intermediate-dose vs standard-dose prophylactic anticoagulation… – πŸ“Š738 citations | πŸ“…2021

  • πŸ“„ Intermediate-dose versus standard-dose prophylactic anticoagulation in patients with COVID-19… – πŸ“Š87 citations | πŸ“…2022

  • πŸ“„ Atorvastatin versus placebo in patients with covid-19 in intensive care… – πŸ“Š76 citations | πŸ“…2022

  • πŸ“„ Evaluation of QT, QT dispersion, and T-wave peak to end time changes… – πŸ“Š61 citations | πŸ“…2013

  • πŸ“„ Association of CT-measured cardiac indices with lung involvement in COVID-19 – πŸ“Š48 citations | πŸ“…2021

  • πŸ“„ Are women more susceptible to ischemic heart disease? A literature overview – πŸ“Š36 citations | πŸ“…2021

  • πŸ“„ Epicardial adipose tissue, inflammatory biomarkers and COVID-19 – πŸ“Š31 citations | πŸ“…2021

  • πŸ“„ Extrinsic compression of left main coronary artery by the pulmonary trunk… – πŸ“Š28 citations | πŸ“…2009

  • πŸ“„ Management of STEMI during COVID-19: Iranian β€œ247” National Committee’s position paper – πŸ“Š26 citations | πŸ“…2021

  • πŸ“„ Prognostic value of inflammatory biomarkers in COVID-19 patients – πŸ“Š15 citations | πŸ“…2021

Guanwei Fan | Cardiovascular research | Best Researcher Award

Published on by Global Academic Awards

Prof. Guanwei Fan | Cardiovascular research | Best Researcher Award

Prof. Guanwei Fan, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, China

Prof. Guanwei Fan, PhD, is a prominent researcher at the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, China. His research focuses on the molecular pharmacology of traditional Chinese medicine in cardiovascular diseases. Prof. Fan has received numerous accolades, including recognition as a national “WR” scientific and technological innovation talent and ranking among the top 2% of scientists globally in recent years. He has published extensively, contributing significantly to the understanding of cardiac repair and treatment methodologies. With a strong commitment to advancing traditional medicine, he continues to impact the field profoundly. πŸ“šβ€οΈ

 

Publication Profile

Scopus

Education

Prof. Guanwei Fan obtained his Doctoral degree from Tianjin University of Traditional Chinese Medicine (09/2005-06/2008) after earning his Master’s degree from the same institution (09/2002-07/2005). His academic background provides a solid foundation for his research endeavors in traditional Chinese medicine.

Research Direction

Prof. Fan specializes in the molecular pharmacology of traditional Chinese medicine, specifically in the context of cardiovascular diseases. His focus on this area demonstrates his commitment to bridging traditional practices with modern scientific methodologies, contributing valuable insights to the field of pharmacology.

Academic and Professional Achievements

Prof. Fan has garnered significant recognition for his contributions to research and innovation. He has been selected as a national “WR” scientific and technological innovation leading talent and enjoys special government subsidies from The State Council. He is also a national candidate for the Millions of Talents Project and has been recognized as a young and middle-aged scientific and technological innovation leading talent by the Ministry of Science and Technology. Additionally, he holds the title of the first Young Qihuang Scholar and has received multiple accolades, including Tianjin Outstanding Youth and Jinmen Medical Talents. Notably, he ranked among the top 2% of the world’s top scientists in the “Impact of 2022” and “Impact of 2021” lists.

Conclusion

Prof. Guanwei Fan is a highly suitable candidate for the Research for Best Researcher Award. His innovative approach to integrating traditional Chinese medicine with modern pharmacological research in cardiovascular diseases sets him apart as a leading figure in his field.

 

Publication Top Notes Β 

  • Zhang, K., Yin, Z., Chen, F., … Wang, Y., Fan, G. Omics-based pharmacological evaluation reveals Yuanhu Zhitong oral liquid ameliorates arthritis by regulating PKC/ERK/NF-ΞΊB signaling pathway. Journal of Ethnopharmacology, 2024. πŸ“–
  • Liu, Z., Bian, X., Li, L., … Liu, X., Fan, G. SENP1-Mediated HSP90ab1 DeSUMOylation in Cardiomyocytes Prevents Myocardial Fibrosis by Paracrine Signaling. Advanced Science, 2024. πŸ“–
  • Lin, J., Chen, Y., Luo, X., Fan, G. Research hotspots and trends of traditional Chinese and western medicine in treatment of heart failure with preserved ejection fraction. Chinese Traditional and Herbal Drugs, 2024. πŸ“–
  • Feng, C., Jiang, H., Fan, G., Li, L., Feng, J. Retrospective Study on the Efficacy of Qi Li Qiang Xin Jiao Nang in Reducing the Risk of Diuretic Resistance in Patients with Acute Decompensated Chronic Heart Failure. Chinese General Practice, 2024. πŸ“–
  • Shi, J., Yang, M.M., Yang, S., … Fan, G., Ma, C. MaiJiTong granule attenuates atherosclerosis by reducing ferroptosis via activating STAT6-mediated inhibition of DMT1 and SOCS1/p53 pathways in LDLRβˆ’/βˆ’ mice. Phytomedicine, 2024. πŸ“–
  • Li, Z., Lyu, C., Pan, G., … Zhang, B., Huang, Y., Fan, G. Strategies and methods for studying interaction between traditional Chinese and western medicine dominated by clinical benefit-risk signals. Chinese Traditional and Herbal Drugs, 2024. πŸ“–
  • Zhang, K., Ji, J., Li, N., Yin, Z., Fan, G. Integrated Metabolomics and Gut Microbiome Analysis Reveals the Efficacy of a Phytochemical Constituent in the Management of Ulcerative Colitis. Molecular Nutrition and Food Research, 2024. πŸ“–
  • Zhao, Y., Zheng, G., Yang, S., … Fan, G., Ma, C. The plant extract PNS mitigates atherosclerosis via promoting Nrf2-mediated inhibition of ferroptosis through reducing USP2-mediated Keap1 deubiquitination. British Journal of Pharmacology, 2024. πŸ“–
  • Wu, L.-L., Yang, B.-R., Meng, X.-Y., Fan, G.-W., Yang, B. Editorial: Artificial intelligence: new hope for critically ill cardiovascular patients. Frontiers in Medicine, 2024. πŸ“–
  • Zhang, L., Lin, J., Zhang, C., … Fan, G., He, F. Recent Advances in the Nanotechnology-Based Applications of Essential Oils. Current Nanoscience, 2024. πŸ“–